Patents by Inventor Artemis STAMBOULIS

Artemis STAMBOULIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10501495
    Abstract: The invention relates to an antimicrobial surface, in particular a surface functionalised with a peptide comprising an antimicrobial moiety. The invention comprises a surface functionalised with a peptide comprising an antimicrobial moiety and a binder moiety, wherein the peptide is immobilized on the surface by electrostatic interactions between the binder moiety and the surface. Further provided is a medical device, a peptide and a method for the immobilization of a peptide.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: December 10, 2019
    Assignees: The University of Birmingham, The Secretary of State for Defence of the United Kingdom of Great Britain and Northern Ireland
    Inventors: Artemis Stamboulis, Felicity Jane de Cogan, Robert Scott, Anna Frances Acushia Peacock
  • Publication number: 20170057998
    Abstract: The invention relates to an antimicrobial surface, in particular a surface functionalised with a peptide comprising an antimicrobial moiety. The invention comprises a surface functionalised with a peptide comprising an antimicrobial moiety and a binder moiety, wherein the peptide is immobilized on the surface by electrostatic interactions between the binder moiety and the surface. Further provided is a medical device, a peptide and a method for the immobilization of a peptide.
    Type: Application
    Filed: February 25, 2015
    Publication date: March 2, 2017
    Applicants: The University of Birmingham, The Secretary of State for Defence of the United Kingdom of Great Britain and Northern Ireland
    Inventors: Artemis Stamboulis, Felicity Jane de Cogan, Robert Scott, Anna Frances Acushia Peacock
  • Publication number: 20160339079
    Abstract: Described herein is a transmembrane delivery system comprising: a pharmaceutically active moiety; and a polypeptide of up to 20 amino acids in length comprising a continuous region of at least 2, more typically at least 4 basic amino acids. Typically the system comprises a polypeptide which has the formula: (B)n(A)m where B is a basic amino acid A is an acidic amino acid, m and n are integers, and n is at least 4, and m is less than n.
    Type: Application
    Filed: January 28, 2015
    Publication date: November 24, 2016
    Inventors: Artemis STAMBOULIS, Ann LOGAN, Felicity Jane DE COGAN, Robert SCOTT, Anna Frances Acushla PEACOCK, Lisa Jayne HILL